© Reuters. FILE PHOTO: Medical worker prepares a dose of AstraZeneca COVID-19 vaccine at a vaccination center in Ronquieres
BRUSSELS (Reuters) -European Union health ministers will hold a meeting on Wednesday on vaccine rollouts after the EU drugs regulator announces its decision on the safety of the AstraZeneca (NASDAQ:) COVID-19 vaccine, the EU presidency said.
Health Minister Marta Temido of Portugal, which holds the EU presidency, will host the gathering from 6 p.m. (1600 GMT) "following the public announcement of the conclusions of the Pharmacovigilance Risk Assessment Committee of EMA on the safety of the AstraZeneca vaccine," a spokeswoman for the Portuguese presidency wrote on Twitter.
EMA plans to announce its decision at 1400 GMT. Experts from the European drug authority have reviewed to what extent some cases of blood clotting in adults who had recently received the AstraZeneca vaccine may be linked to the injections.
"The meeting is aimed at harmonising the positions of the different EU member states, not only in order to halt the spread of disinformation, but also to reach a common understanding regarding vaccination efforts in the European Union," the Portuguese presidency said in a statement.
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.